December 24th, 2011 by BarbaraFederOstrov in Health Policy, News
No Comments »
Kim Jong Il: Of course we’re going to highlight the lowlights of the North Korean leader’s health: CNN has the scoop on the dictator’s cause of death and previous illnesses. Knight Science Journalism Tracker’s Paul Raeburn rounds up previous analyses of Kim Jong Il’s psychological profile.
Breast Cancer: Companies are trying to build a better mammogram as they compete for a bigger slice of the $6 billion-and-growing medical imaging market, Sierra Jiminez reports for Fortune. Nearly 300,000 American women have been diagnosed with breast cancer this year.
Health Reform: The U.S. Supreme Court will devote an unprecedented week of oral argument over health reform when Read more »
*This blog post was originally published at Reporting on Health - The Reporting on Health Daily Briefing*
October 12th, 2011 by Peggy Polaneczky, M.D. in Health Tips, Opinion
No Comments »
A well-written and balanced article on mammography from USA Today may help move the conversation about this screening test away from hype and a bit closer to reality. The title – “Mammogram is ‘terribly imperfect’, though recommended.”
For women in their 40s, mammograms reduce the risk of dying from breast cancer by about 15%… But mammograms miss some cancers and raise false alarms about others, causing women to go through unnecessary follow-up tests… “We’re saying, ‘Mammography is a terribly imperfect test, but we’re recommending women get it,’” Brawley says. “The task force was saying, ‘Mammography is a terribly imperfect test, and Read more »
*This blog post was originally published at The Blog That Ate Manhattan*
July 28th, 2011 by Peggy Polaneczky, M.D. in Health Tips, Research
No Comments »
Most women in their 40′s believe they should have annual mammograms, regardless of what screening regimen their doctor might recommend.
So say researchers in Massachusetts who surveyed women (primarily white, highly educated) ages 39-49 presenting for annual checkups. They gave the women a fact sheet about the new USPSTF guidelines on mammogram screening in their age group, and asked them to read one of two articles either supporting or opposing the guidelines. The researchers then asked women about their beliefs, concerns and attitudes about breast cancer and mammogram screening. Here’s what they found -
- Women overwhelmingly want annual mammograms – Close to 90% of women surveyed felt they should have annual mammograms, regardless of what their doctor might recommend.
- Women overestimate breast cancer risks – Eighty eight percent overestimated their lifetime risk for the disease, with the average estimate being 37%. (The correct lifetime risk for breast cancer is 12%). This is consistent with previous research on breast cancer beliefs.
- The media may not influence women’s opinions about screening guidelines – Read more »
*This blog post was originally published at The Blog That Ate Manhattan*
July 28th, 2010 by Davis Liu, M.D. in Better Health Network, Health Policy, News, Opinion, Research
2 Comments »
The American College of Obstetricians and Gynecologists (ACOG) recently reiterated their position that Pap smears should be performed on healthy women starting at age 21. This is different from the past which recommended screening for cervical cancer at either three years after the time a woman became sexually active or age 21, whichever occurred first.
How will the public respond to this change?
Over the past year there have been plenty of announcements from the medical profession regarding to the appropriateness of PSA screening for prostate cancer and the timing of mammogram screening for breast cancer. Understandably, some people may view these changes in recommendations as the rationing of American healthcare. Read more »
*This blog post was originally published at Saving Money and Surviving the Healthcare Crisis*
July 19th, 2010 by JenniferKearneyStrouse in Better Health Network, Health Policy, News
No Comments »
An FDA advisory panel has voted that the diabetes drug Avandia (rosiglitazone) can remain on the market, but recommended further warnings associated with its use. The panel was divided, the New York Times reported, with 12 of 33 members saying the drug should be removed from the market, 10 voting to restrict sales and strengthen the warning label, 7 recommending only strengthening the warning label, and 3 voting for no change. One panel member abstained. (New York Times)
The White House yesterday announced which preventive services would be available at no charge to patients under the new healthcare legislation. Adult patients who choose a health plan after September 23 will receive mammograms, diabetes screening, and tobacco cessation counseling, among other services, at no increased cost, but insurers have said patients will eventually pay in the form of higher premiums, the Wall Street Journal reported. (Wall Street Journal)
*This blog post was originally published at ACP Internist*
